Success Story: Biology Researcher Earns EB-1A Approval After Successfully Responding to RFE
Client’s Testimonial:
"Thank you for your work putting together my RFE response! Yes, I'm happy to share the success story.”
On May 27th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Fellow in the Field of Biology (Approval Notice).
General Field: Biology
Position at the Time of Case Filing: Research Fellow
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: May 27th, 2026
Processing Time: 12 months and 15 days
Case Summary:
An EB-1A was recently approved for a highly accomplished biology researcher born in China. The petition was approved following a successful RFE response prepared by our expert team, filed under premium processing.
Research Leadership and Global Recognition
Currently working as a research fellow in the field of biology, the client holds a Ph.D. in systems biology and has established deep expertise as one of the leading specialists in cell biology, cancer biology, immunology, systems biology, and bioinformatics. The client currently conducts cutting-edge research on the molecular mechanisms underlying tumorigenesis and drug response in cancer, leveraging single-cell sequencing technologies and high-throughput microscopy to examine molecular heterogeneity in cancer cells.
The client's scholarly record reflects a rare combination of productivity, impact, and scientific leadership:
- 11 peer-reviewed journal articles (2 first-authored) and 1 preprint, published in top-ranked venues including journals with impact factors as high as 50.5, ranked #1 in their categories by Google Scholar
- 496 citations
- At least 27 completed peer reviews for a high-impact journal
Expert Endorsements
To build the EB-1A petition, our firm included 6 expert recommendation letters from internationally recognized scientists. One expert stated:
"As a renowned expert in the field of biology, [Client] has consistently demonstrated an unwavering commitment to enhancing the field’s comprehension of fundamental cellular processes."
EB-1A Approval and Outlook
We are honored to have supported this outstanding researcher and look forward to witnessing continued advances in cancer biology, immune system regulation, and the molecular mechanisms driving tumor growth, work that holds immense promise for improving patient outcomes and strengthening U.S. scientific leadership for years to come.

